Sale!

Enhanced Liver Fibrosis ELF Panel Test

1,050 د.إ

-10%

The Enhanced Liver Fibrosis (ELF) Panel Test is a sophisticated diagnostic tool used to assess the extent of liver fibrosis, which is the scarring of the liver as a result of chronic liver disease. By measuring a set of biomarkers in the blood, including hyaluronic acid, tissue inhibitor of metalloproteinase 1 (TIMP-1), and procollagen III amino-terminal peptide (PIIINP), the ELF test provides a score that helps in evaluating the severity of liver fibrosis. This non-invasive method offers a significant advantage over traditional liver biopsy by reducing patient discomfort and risk of complications.

At DNA Labs UAE, the ELF Panel Test is available for a cost of 1050 AED. The facility is known for its state-of-the-art technology and experienced professionals who ensure accurate and reliable results. Conducting the ELF test at DNA Labs UAE offers patients a convenient and efficient way to monitor liver health and aids healthcare providers in making informed decisions regarding the management of chronic liver diseases.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ENHANCED LIVER FIBROSIS ELF PANEL Test

Test Name: ENHANCED LIVER FIBROSIS ELF PANEL Test

Components:

  • Hyaluronic acid (HA)
  • Amino terminal Propeptide type III Procollagen (PIIINP)
  • Tissue inhibitor Metalloproteinase 1 (TIMP-1)
  • ELF score

Price: 1050.0 AED

Sample Condition: 3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is mandatory.

Report Delivery: SampleMon / Thu by 4 pm; Report Next day

Method: Chemiluminescent Microparticle Immunoassay

Test type: Disorders of Liver

Doctor: Gastroenterologist, Physician

Test Department:

Pre Test Information: Overnight fasting is mandatory.

Test Details:

The Enhanced Liver Fibrosis (ELF) Panel test is a blood test that is used to assess the severity of liver fibrosis. Liver fibrosis is the scarring of the liver tissue that occurs as a result of chronic liver disease. The ELF Panel test measures three specific biomarkers in the blood: hyaluronic acid (HA), tissue inhibitor of metalloproteinase 1 (TIMP-1), and amino-terminal propeptide of type III collagen (PIIINP). These biomarkers are associated with the production and degradation of liver fibrosis. By measuring the levels of these biomarkers, the ELF Panel test can provide a numerical score that indicates the extent of liver fibrosis. The higher the score, the more severe the fibrosis.

The ELF Panel test is often used as a non-invasive alternative to liver biopsy, which is the gold standard for assessing liver fibrosis. Liver biopsy involves the removal of a small sample of liver tissue for examination under a microscope. However, liver biopsy is an invasive procedure that carries some risks and may not be suitable for all patients.

The ELF Panel test can be used to monitor the progression of liver fibrosis over time and to guide treatment decisions. It is particularly useful in patients with chronic liver diseases such as hepatitis B, hepatitis C, and non-alcoholic fatty liver disease (NAFLD).

Overall, the ELF Panel test is a valuable tool for assessing liver fibrosis non-invasively and can provide important information for the management of patients with chronic liver diseases.

Test Name ENHANCED LIVER FIBROSIS ELF PANEL Test
Components *Hyaluronic acid (HA)*Amino terminal Propeptide type III Procollagen (PIIINP) *Tissue inhibitor Metalloproteinase 1 (TIMP-1)*ELF score
Price 1050.0 AED
Sample Condition 3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is mandatory.
Report Delivery SampleMon / Thu by 4 pm; Report Next day
Method Chemiluminescent Microparticle Immunoassay
Test type Disorders of Liver
Doctor Gastroenterologist, Physician
Test Department:
Pre Test Information Overnight fasting is mandatory.
Test Details

The Enhanced Liver Fibrosis (ELF) Panel test is a blood test that is used to assess the severity of liver fibrosis. Liver fibrosis is the scarring of the liver tissue that occurs as a result of chronic liver disease. The ELF Panel test measures three specific biomarkers in the blood: hyaluronic acid (HA), tissue inhibitor of metalloproteinase 1 (TIMP-1), and amino-terminal propeptide of type III collagen (PIIINP).

These biomarkers are associated with the production and degradation of liver fibrosis. By measuring the levels of these biomarkers, the ELF Panel test can provide a numerical score that indicates the extent of liver fibrosis. The higher the score, the more severe the fibrosis.

The ELF Panel test is often used as a non-invasive alternative to liver biopsy, which is the gold standard for assessing liver fibrosis. Liver biopsy involves the removal of a small sample of liver tissue for examination under a microscope. However, liver biopsy is an invasive procedure that carries some risks and may not be suitable for all patients.

The ELF Panel test can be used to monitor the progression of liver fibrosis over time and to guide treatment decisions. It is particularly useful in patients with chronic liver diseases such as hepatitis B, hepatitis C, and non-alcoholic fatty liver disease (NAFLD).

Overall, the ELF Panel test is a valuable tool for assessing liver fibrosis non-invasively and can provide important information for the management of patients with chronic liver diseases.